Figure 3From: Re-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels — a four-years prospective cohort study in Taiwan Cumulative renal (A) and overall survival (B) based on hypoalbuminemia and presence of more than 3 metabolic complications in patients with eGFR below 45 mL/min per 1.73 m 2 (log-rank test, p < 0.001). Back to article page